James G. Krueger

Dr. Krueger is the Director of the Milstein Medical Research Program and D. Martin Carter Professor in Clinical Investigation at Rockefeller University in New York. Dr. Krueger’s group at Rockefeller was the first to conduct clinical trials with specific, targeted immune antagonists in psoriasis. Recent focus of the Krueger group has been definition of new inflammatory pathways, as well as new types of inflammatory cells in psoriasis lesions that are now being targeted with new biologic drugs. Dr. Krueger is certified by the American Board of Dermatology. Dr. Krueger earned his PhD in virology and cell biology from the Rockefeller University. He earned an MD from Cornell University Medical College, where he also completed his internship in internal medicine and residency in dermatology.